Compare Stocks → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison OTCMKTS:DGNOFOTCMKTS:OROXFOTCMKTS:PDGRYOTCMKTS:PEMIFOTCMKTS:PRVCF Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDGNOFDIAGNOS$0.21+5.2%$0.21$0.18▼$0.43$15.57M0.241,519 shs37,000 shsOROXFOrosur Mining$0.19$0.16$0.06▼$0.19$39.16M-0.01N/AN/APDGRYPDG RLTY S A EM/S$2.00$2.00$2.00▼$2.00$3.22M0.3N/AN/APEMIFPure Energy Minerals$0.29+7.4%$0.29$0.24▼$1.30$9.41M0.8721,512 shs25,763 shsPRVCFPreveCeutical Medical$0.02$0.02$0.01▼$0.03$8.67M0.7360,269 shsN/A20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDGNOFDIAGNOS+5.17%-3.96%+21.02%-10.96%-1.93%OROXFOrosur Mining0.00%0.00%0.00%+233.80%+281.00%PDGRYPDG RLTY S A EM/S0.00%0.00%0.00%0.00%-99.00%PEMIFPure Energy Minerals+5.49%+12.09%-3.76%-9.71%-21.05%PRVCFPreveCeutical Medical+0.25%+11.23%-4.47%-14.07%-9.27%top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (Ad)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution…MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationDGNOFDIAGNOSN/AN/AN/AN/AN/AN/AN/AN/AOROXFOrosur MiningN/AN/AN/AN/AN/AN/AN/AN/APDGRYPDG RLTY S A EM/SN/AN/AN/AN/AN/AN/AN/AN/APEMIFPure Energy MineralsN/AN/AN/AN/AN/AN/AN/AN/APRVCFPreveCeutical MedicalN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDGNOFDIAGNOSN/AN/AN/AN/AOROXFOrosur MiningN/AN/AN/AN/APDGRYPDG RLTY S A EM/SN/AN/AN/AN/APEMIFPure Energy MineralsN/AN/AN/AN/APRVCFPreveCeutical MedicalN/AN/AN/AN/ASales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDGNOFDIAGNOS$370K44.25N/AN/A($0.02) per share-10.68OROXFOrosur MiningN/AN/AN/AN/A($0.04) per shareN/APDGRYPDG RLTY S A EM/SN/AN/AN/AN/AN/AN/APEMIFPure Energy Minerals$400K24.81N/AN/A$0.80 per share0.37PRVCFPreveCeutical MedicalN/AN/AN/AN/A($0.01) per shareN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDGNOFDIAGNOS-$1.88M-$0.04N/A∞N/A-1,553.79%N/A-297.10%N/AOROXFOrosur Mining-$1.79M-$0.01N/A∞N/AN/AN/A-16.78%N/APDGRYPDG RLTY S A EM/SN/AN/A0.00∞N/AN/AN/AN/AN/APEMIFPure Energy Minerals-$260K-$0.01N/A∞N/A-113.48%-1.76%-1.75%N/APRVCFPreveCeutical Medical-$1.14MN/A0.00∞N/AN/AN/A-272.69%N/ALatest PRVCF, OROXF, DGNOF, PDGRY, and PEMIF EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails2/29/2024Q2 2024PEMIFPure Energy MineralsN/A-$0.01-$0.01-$0.01N/A$0.10 million2/28/2024Q3 2024DGNOFDIAGNOSN/A-$0.01-$0.01-$0.01N/A$0.04 millionDividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDGNOFDIAGNOSN/AN/AN/AN/AN/AOROXFOrosur MiningN/AN/AN/AN/AN/APDGRYPDG RLTY S A EM/SN/AN/AN/AN/AN/APEMIFPure Energy MineralsN/AN/AN/AN/AN/APRVCFPreveCeutical MedicalN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDGNOFDIAGNOSN/A0.790.79OROXFOrosur MiningN/A0.230.23PDGRYPDG RLTY S A EM/SN/AN/AN/APEMIFPure Energy MineralsN/A7.697.69PRVCFPreveCeutical MedicalN/A0.020.02OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDGNOFDIAGNOSN/AOROXFOrosur MiningN/APDGRYPDG RLTY S A EM/SN/APEMIFPure Energy MineralsN/APRVCFPreveCeutical MedicalN/AInsider OwnershipCompanyInsider OwnershipDGNOFDIAGNOSN/AOROXFOrosur MiningN/APDGRYPDG RLTY S A EM/SN/APEMIFPure Energy MineralsN/APRVCFPreveCeutical MedicalN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableDGNOFDIAGNOSN/A76.65 millionN/ANot OptionableOROXFOrosur Mining7205.58 millionN/ANot OptionablePDGRYPDG RLTY S A EM/SN/A1.61 millionN/ANot OptionablePEMIFPure Energy MineralsN/A33.97 millionN/ANot OptionablePRVCFPreveCeutical MedicalN/A535.30 millionN/ANot OptionablePRVCF, OROXF, DGNOF, PDGRY, and PEMIF HeadlinesSourceHeadlinePreveCeutical Medical Inc PRVCFmorningstar.com - March 15 at 2:53 PMPreveCeutical & Endosane Announces Innovative Preclinical Approaches to Assess Brain Availability of CBD And Pharmacologically Relevant Doses Following Intranasal CBD Applicationfinance.yahoo.com - September 18 at 10:18 AMPreveCeutical Showcases Dynamic Evolution in AI Strategyfinance.yahoo.com - September 12 at 7:46 AMPreveCeutical Files Two Family Patents of Sol-Gel Cannabinoid Formulation and Antiviral Use & Cyclic Peptides and Uses Thereoffinance.yahoo.com - June 28 at 7:13 AMPreveCeutical Medical - Sol-Gel and Uses thereof Patent Updatefinance.yahoo.com - May 30 at 8:48 AMPreveCeutical Medical Launches Clinical Artificial Intelligence Divisionfinance.yahoo.com - April 24 at 9:40 AMPreveCeutical Medical Announces Live Interactive Q&A Video Conferencefinance.yahoo.com - April 20 at 9:38 AMPreveCeutical Medical Announces Frontiers Media SA Publication Featuring Data from its Analgesic Program for the Treatment of Peptide-based Therapeutics for Moderate to Severe Painfinance.yahoo.com - April 4 at 9:17 AMPreveCeutical Initiates Non-Analgesic (Painkiller) Program, Clinical Development Program & Disclosure Committeefinance.yahoo.com - March 20 at 7:39 AMPRVCF PreveCeutical Medical Inc.seekingalpha.com - February 23 at 6:51 PMAppointment of C. Evan Ballantyne to PreveCeutical's Board of Directorsfinance.yahoo.com - February 21 at 7:47 AMPreveCeutical Awards ICON Analgesic Program (Painkiller) Clinical Developmentfinance.yahoo.com - February 7 at 12:47 PMPreveCeutical, Endosane team up for sol-gel tech use in cannabis therapymsn.com - January 14 at 11:41 PMPreveCeutical Enters into License Option Agreement with Endosane Pharmaceuticalsfinance.yahoo.com - January 12 at 8:59 AMPreveCeutical Signs Intercompany Sol-Gel License Agreementfinance.yahoo.com - January 9 at 9:00 AMThe Power Play by The Market Herald Releases New Interviews with Eloro Resources, Prospera, Datametrex, Gamelancer Media, Infinity Stone Ventures and PreveCeutical Medical Discussing Their Latest Newsfinance.yahoo.com - November 23 at 11:37 PMPreveCeutical Files Application for D-amino Acid Peptidesfinance.yahoo.com - November 21 at 8:02 AMPreveCeutical Medical Inc.: PreveCeutical Announces Conversion of Debtfinanznachrichten.de - November 12 at 10:22 AMPreveCeutical Announces Conversion of Debtfinance.yahoo.com - November 12 at 10:22 AMAppointment of Kathleen Rotika to PreveCeutical's Board of Directorsfinance.yahoo.com - October 20 at 3:11 PMPreveCeutical Announces Resignation of Board of Director Memberfinance.yahoo.com - September 17 at 12:05 AMAppointment of Sachin Nanavati to PreveCeutical's Board of Directorsfinance.yahoo.com - September 6 at 9:29 AMPreveCeutical Announces Change in Directors and Investor Awareness Servicesfinance.yahoo.com - May 27 at 5:38 PMArticle Based on PreveCeutical's Pain Management Peptides Program Published in the British Journal of Pharmacologyfinance.yahoo.com - May 9 at 8:22 AMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCompany DescriptionsDIAGNOSOTCMKTS:DGNOFDIAGNOS Inc. provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence. DIAGNOS Inc. was founded in 1998 and is headquartered in Brossard, Canada.Orosur MiningOTCMKTS:OROXFOrosur Mining Inc. engages in identifying and advancing mineral projects in South America. Its flagship project is the Anzá gold project located in the Middle Cauca Belt in northern Colombia. The company was formerly known as Uruguay Mineral Exploration Inc. and changed its name to Orosur Mining Inc. in January 2010. Orosur Mining Inc. was incorporated in 1996 and is based in Toronto, Canada.PDG RLTY S A EM/SOTCMKTS:PDGRYPDG Realty S.A. Empreendimentos e Participacoes operates in the real estate industry in Brazil. It engages in the acquisition and development of real estate properties; and acquisition of investment properties. The company was founded in 2003 and is headquartered in São Paulo, Brazil.Pure Energy MineralsOTCMKTS:PEMIFPure Energy Minerals Limited acquires, explores, and develops mineral properties. Its primary project is the Clayton Valley lithium brine project located in Clayton Valley, Esmeralda County, Nevada. The company was formerly known as Harmony Gold Corp. and changed its name to Pure Energy Minerals Limited in October 2012. Pure Energy Minerals Limited is headquartered in Vancouver, Canada.PreveCeutical MedicalOTCMKTS:PRVCFPreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including pain, inflammation, seizures, and neurological disorders; Non-Addictive Analgesic for pain management; BSV Peptide Program that targets cancer progression; and Dual Gene Therapy for type 2 diabetes and obesity. The company also develops a range of medicinal cannabis-based products. PreveCeutical Medical Inc. is headquartered in Vancouver, Canada. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.